Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 893 entries
Sorted by: Best Match Show Resources per page
The European Society of Gastrointestinal Endoscopy Quality Improvement Initiative: developing performance measures.

United European gastroenterology journal

Rutter MD, Senore C, Bisschops R, Domagk D, Valori R, Kaminski MF, Spada C, Bretthauer M, Bennett C, Bellisario C, Minozzi S, Hassan C, Rees C, Dinis-Ribeiro M, Hucl T, Ponchon T, Aabakken L, Fockens P.
PMID: 26966520
United European Gastroenterol J. 2016 Feb;4(1):30-41. doi: 10.1177/2050640615624631. Epub 2015 Dec 17.

The European Society of Gastrointestinal Endoscopy (ESGE) and United European Gastroenterology (UEG) have a vision to create a thriving community of endoscopy services across Europe, collaborating with each other to provide high quality, safe, accurate, patient-centered and accessible endoscopic...

Cite
Rutter MD, Senore C, Bisschops R, et al. The European Society of Gastrointestinal Endoscopy Quality Improvement Initiative: developing performance measures. United European Gastroenterol J. 2015;4(1):30-41doi: 10.1177/2050640615624631.
Rutter, M. D., Senore, C., Bisschops, R., Domagk, D., Valori, R., Kaminski, M. F., Spada, C., Bretthauer, M., Bennett, C., Bellisario, C., Minozzi, S., Hassan, C., Rees, C., Dinis-Ribeiro, M., Hucl, T., Ponchon, T., Aabakken, L., & Fockens, P. (2016). The European Society of Gastrointestinal Endoscopy Quality Improvement Initiative: developing performance measures. United European gastroenterology journal, 4(1), 30-41. https://doi.org/10.1177/2050640615624631
Rutter, Matthew D, et al. "The European Society of Gastrointestinal Endoscopy Quality Improvement Initiative: developing performance measures." United European gastroenterology journal vol. 4,1 (2016): 30-41. doi: https://doi.org/10.1177/2050640615624631
Rutter MD, Senore C, Bisschops R, Domagk D, Valori R, Kaminski MF, Spada C, Bretthauer M, Bennett C, Bellisario C, Minozzi S, Hassan C, Rees C, Dinis-Ribeiro M, Hucl T, Ponchon T, Aabakken L, Fockens P. The European Society of Gastrointestinal Endoscopy Quality Improvement Initiative: developing performance measures. United European Gastroenterol J. 2016 Feb;4(1):30-41. doi: 10.1177/2050640615624631. Epub 2015 Dec 17. PMID: 26966520; PMCID: PMC4766555.
Copy Download .nbib Format: NLM
Response to Forbes's comment.

United European gastroenterology journal

Ciacci C, Ciclitira P, Hadjivassiliou M, Kaukinen K, Ludvigsson JF, McGough N, Sanders DS, Woodward J, Leonard JN, Swift GL.
PMID: 26966536
United European Gastroenterol J. 2016 Feb;4(1):153. doi: 10.1177/2050640615614742. Epub 2016 Feb 11.

No abstract available.

Cite
Ciacci C, Ciclitira P, Hadjivassiliou M, et al. Response to Forbes's comment. United European Gastroenterol J. 2016;4(1):153doi: 10.1177/2050640615614742.
Ciacci, C., Ciclitira, P., Hadjivassiliou, M., Kaukinen, K., Ludvigsson, J. F., McGough, N., Sanders, D. S., Woodward, J., Leonard, J. N., & Swift, G. L. (2016). Response to Forbes's comment. United European gastroenterology journal, 4(1), 153. https://doi.org/10.1177/2050640615614742
Ciacci, Carolina, et al. "Response to Forbes's comment." United European gastroenterology journal vol. 4,1 (2016): 153. doi: https://doi.org/10.1177/2050640615614742
Ciacci C, Ciclitira P, Hadjivassiliou M, Kaukinen K, Ludvigsson JF, McGough N, Sanders DS, Woodward J, Leonard JN, Swift GL. Response to Forbes's comment. United European Gastroenterol J. 2016 Feb;4(1):153. doi: 10.1177/2050640615614742. Epub 2016 Feb 11. PMID: 26966536; PMCID: PMC4766554.
Copy Download .nbib Format: NLM
The two sides of the coin: Similarities and differences in the pathomechanisms of fistulas and stricture formations in irritable bowel disease.

United European gastroenterology journal

Scharl M, Bruckner RS, Rogler G.
PMID: 27536360
United European Gastroenterol J. 2016 Aug;4(4):506-14. doi: 10.1177/2050640616635957. Epub 2016 Feb 19.

Fistulas and fibrosis or strictures represent frequent complications in irritable bowel disease (IBD) patients. To date, treatment options for fistulas are limited and surgery is often required. Similarly, no preventive treatment for fibrosis and stricture formation has been established....

Cite
Scharl M, Bruckner RS, Rogler G. The two sides of the coin: Similarities and differences in the pathomechanisms of fistulas and stricture formations in irritable bowel disease. United European Gastroenterol J. 2016;4(4):506-14doi: 10.1177/2050640616635957.
Scharl, M., Bruckner, R. S., & Rogler, G. (2016). The two sides of the coin: Similarities and differences in the pathomechanisms of fistulas and stricture formations in irritable bowel disease. United European gastroenterology journal, 4(4), 506-14. https://doi.org/10.1177/2050640616635957
Scharl, Michael, et al. "The two sides of the coin: Similarities and differences in the pathomechanisms of fistulas and stricture formations in irritable bowel disease." United European gastroenterology journal vol. 4,4 (2016): 506-14. doi: https://doi.org/10.1177/2050640616635957
Scharl M, Bruckner RS, Rogler G. The two sides of the coin: Similarities and differences in the pathomechanisms of fistulas and stricture formations in irritable bowel disease. United European Gastroenterol J. 2016 Aug;4(4):506-14. doi: 10.1177/2050640616635957. Epub 2016 Feb 19. PMID: 27536360; PMCID: PMC4971795.
Copy Download .nbib Format: NLM
UEG E-learning: The future has arrived.

United European gastroenterology journal

[No authors listed]
PMID: 26425344
United European Gastroenterol J. 2015 Aug;3(4):399. doi: 10.1177/2050640615596317.

No abstract available.

Cite
UEG E-learning: The future has arrived. United European Gastroenterol J. 2015;3(4):399doi: 10.1177/2050640615596317.
(2015). UEG E-learning: The future has arrived. United European gastroenterology journal, 3(4), 399. https://doi.org/10.1177/2050640615596317
"UEG E-learning: The future has arrived." United European gastroenterology journal vol. 3,4 (2015): 399. doi: https://doi.org/10.1177/2050640615596317
UEG E-learning: The future has arrived. United European Gastroenterol J. 2015 Aug;3(4):399. doi: 10.1177/2050640615596317. PMID: 26425344; PMCID: PMC4528215.
Copy Download .nbib Format: NLM
Cytokine and anti-cytokine therapies in prevention or treatment of fibrosis in IBD.

United European gastroenterology journal

Jacob N, Targan SR, Shih DQ.
PMID: 27536363
United European Gastroenterol J. 2016 Aug;4(4):531-40. doi: 10.1177/2050640616649356. Epub 2016 May 10.

The frequency of fibrosing Crohn's disease (CD) is significant, with approximately 40% of CD patients with ileal disease developing clinically apparent strictures throughout their lifetime. Although strictures may be subdivided into fibrotic, inflammatory, or mixed forms, despite immunosuppressive therapy...

Cite
Jacob N, Targan SR, Shih DQ. Cytokine and anti-cytokine therapies in prevention or treatment of fibrosis in IBD. United European Gastroenterol J. 2016;4(4):531-40doi: 10.1177/2050640616649356.
Jacob, N., Targan, S. R., & Shih, D. Q. (2016). Cytokine and anti-cytokine therapies in prevention or treatment of fibrosis in IBD. United European gastroenterology journal, 4(4), 531-40. https://doi.org/10.1177/2050640616649356
Jacob, Noam, et al. "Cytokine and anti-cytokine therapies in prevention or treatment of fibrosis in IBD." United European gastroenterology journal vol. 4,4 (2016): 531-40. doi: https://doi.org/10.1177/2050640616649356
Jacob N, Targan SR, Shih DQ. Cytokine and anti-cytokine therapies in prevention or treatment of fibrosis in IBD. United European Gastroenterol J. 2016 Aug;4(4):531-40. doi: 10.1177/2050640616649356. Epub 2016 May 10. PMID: 27536363; PMCID: PMC4971798.
Copy Download .nbib Format: NLM
Optimized contrast-enhanced ultrasonography for characterization of focal liver lesions in cirrhosis: A single-center retrospective study.

United European gastroenterology journal

de Sio I, Iadevaia MD, Vitale LM, Niosi M, Del Prete A, de Sio C, Romano L, Funaro A, Meucci R, Federico A, Loguercio C, Romano M.
PMID: 25083285
United European Gastroenterol J. 2014 Aug;2(4):279-87. doi: 10.1177/2050640614538964.

BACKGROUND: Hepatocellular carcinoma (HCC) is the leading cause of death amongst cirrhotic patients. Its diagnosis and discrimination from non-HCC malignant lesions in cirrhosis includes contrast enhanced computed tomography (CECT), contrast enhanced magnetic resonance imaging (CEMRI), or, in selected cases,...

Cite
de Sio I, Iadevaia MD, Vitale LM, et al. Optimized contrast-enhanced ultrasonography for characterization of focal liver lesions in cirrhosis: A single-center retrospective study. United European Gastroenterol J. 2014;2(4):279-87doi: 10.1177/2050640614538964.
de Sio, I., Iadevaia, M. D., Vitale, L. M., Niosi, M., Del Prete, A., de Sio, C., Romano, L., Funaro, A., Meucci, R., Federico, A., Loguercio, C., & Romano, M. (2014). Optimized contrast-enhanced ultrasonography for characterization of focal liver lesions in cirrhosis: A single-center retrospective study. United European gastroenterology journal, 2(4), 279-87. https://doi.org/10.1177/2050640614538964
de Sio, Ilario, et al. "Optimized contrast-enhanced ultrasonography for characterization of focal liver lesions in cirrhosis: A single-center retrospective study." United European gastroenterology journal vol. 2,4 (2014): 279-87. doi: https://doi.org/10.1177/2050640614538964
de Sio I, Iadevaia MD, Vitale LM, Niosi M, Del Prete A, de Sio C, Romano L, Funaro A, Meucci R, Federico A, Loguercio C, Romano M. Optimized contrast-enhanced ultrasonography for characterization of focal liver lesions in cirrhosis: A single-center retrospective study. United European Gastroenterol J. 2014 Aug;2(4):279-87. doi: 10.1177/2050640614538964. PMID: 25083285; PMCID: PMC4114116.
Copy Download .nbib Format: NLM
Allele-specific transcriptional activity of the variable number of tandem repeats of the inducible nitric oxide synthase gene is associated with idiopathic achalasia.

United European gastroenterology journal

Sarnelli G, Grosso M, Palumbo I, Pesce M, D'Alessandro A, Zaninotto G, Annese V, Petruzzelli R, Izzo P, Sepulveres R, Bruzzese D, Esposito G, Cuomo R.
PMID: 28344787
United European Gastroenterol J. 2017 Mar;5(2):200-207. doi: 10.1177/2050640616648870. Epub 2016 Jul 08.

BACKGROUND: Polymorphisms of genes involved in the regulation of the immune response are risk factors for achalasia, but their contribution to disease pathogenesis is unknown. Nitric oxide is involved both in immune function and inhibitory neurotransmission.OBJECTIVE: The objective of...

Cite
Sarnelli G, Grosso M, Palumbo I, et al. Allele-specific transcriptional activity of the variable number of tandem repeats of the inducible nitric oxide synthase gene is associated with idiopathic achalasia. United European Gastroenterol J. 2016;5(2):200-207doi: 10.1177/2050640616648870.
Sarnelli, G., Grosso, M., Palumbo, I., Pesce, M., D'Alessandro, A., Zaninotto, G., Annese, V., Petruzzelli, R., Izzo, P., Sepulveres, R., Bruzzese, D., Esposito, G., & Cuomo, R. (2017). Allele-specific transcriptional activity of the variable number of tandem repeats of the inducible nitric oxide synthase gene is associated with idiopathic achalasia. United European gastroenterology journal, 5(2), 200-207. https://doi.org/10.1177/2050640616648870
Sarnelli, Giovanni, et al. "Allele-specific transcriptional activity of the variable number of tandem repeats of the inducible nitric oxide synthase gene is associated with idiopathic achalasia." United European gastroenterology journal vol. 5,2 (2017): 200-207. doi: https://doi.org/10.1177/2050640616648870
Sarnelli G, Grosso M, Palumbo I, Pesce M, D'Alessandro A, Zaninotto G, Annese V, Petruzzelli R, Izzo P, Sepulveres R, Bruzzese D, Esposito G, Cuomo R. Allele-specific transcriptional activity of the variable number of tandem repeats of the inducible nitric oxide synthase gene is associated with idiopathic achalasia. United European Gastroenterol J. 2017 Mar;5(2):200-207. doi: 10.1177/2050640616648870. Epub 2016 Jul 08. PMID: 28344787; PMCID: PMC5349359.
Copy Download .nbib Format: NLM
A PPAR-gamma agonist protects from radiation-induced intestinal toxicity.

United European gastroenterology journal

Mangoni M, Sottili M, Gerini C, Desideri I, Bastida C, Pallotta S, Castiglione F, Bonomo P, Meattini I, Greto D, Cappelli S, Di Brina L, Loi M, Biti G, Livi L.
PMID: 28344789
United European Gastroenterol J. 2017 Mar;5(2):218-226. doi: 10.1177/2050640616640443. Epub 2016 Jul 08.

OBJECTIVE: Because of its anti-inflammatory, anti-fibrotic, anti-apoptotic and anti-neoplastic properties, the PPAR-γ agonist rosiglitazone is an interesting drug for investigating for use in the prevention and treatment of radiation-induced intestinal damage. We aimed to evaluate the radioprotective effect of...

Cite
Mangoni M, Sottili M, Gerini C, et al. A PPAR-gamma agonist protects from radiation-induced intestinal toxicity. United European Gastroenterol J. 2016;5(2):218-226doi: 10.1177/2050640616640443.
Mangoni, M., Sottili, M., Gerini, C., Desideri, I., Bastida, C., Pallotta, S., Castiglione, F., Bonomo, P., Meattini, I., Greto, D., Cappelli, S., Di Brina, L., Loi, M., Biti, G., & Livi, L. (2017). A PPAR-gamma agonist protects from radiation-induced intestinal toxicity. United European gastroenterology journal, 5(2), 218-226. https://doi.org/10.1177/2050640616640443
Mangoni, Monica, et al. "A PPAR-gamma agonist protects from radiation-induced intestinal toxicity." United European gastroenterology journal vol. 5,2 (2017): 218-226. doi: https://doi.org/10.1177/2050640616640443
Mangoni M, Sottili M, Gerini C, Desideri I, Bastida C, Pallotta S, Castiglione F, Bonomo P, Meattini I, Greto D, Cappelli S, Di Brina L, Loi M, Biti G, Livi L. A PPAR-gamma agonist protects from radiation-induced intestinal toxicity. United European Gastroenterol J. 2017 Mar;5(2):218-226. doi: 10.1177/2050640616640443. Epub 2016 Jul 08. PMID: 28344789; PMCID: PMC5349355.
Copy Download .nbib Format: NLM
How to get your work published: Tricks and pearls.

United European gastroenterology journal

Ianiro G, Simren M.
PMID: 28344800
United European Gastroenterol J. 2017 Mar;5(2):300-301. doi: 10.1177/2050640617695067. Epub 2017 Mar 01.

No abstract available.

Cite
Ianiro G, Simren M. How to get your work published: Tricks and pearls. United European Gastroenterol J. 2017;5(2):300-301doi: 10.1177/2050640617695067.
Ianiro, G., & Simren, M. (2017). How to get your work published: Tricks and pearls. United European gastroenterology journal, 5(2), 300-301. https://doi.org/10.1177/2050640617695067
Ianiro, Gianluca, and Simren, Magnus. "How to get your work published: Tricks and pearls." United European gastroenterology journal vol. 5,2 (2017): 300-301. doi: https://doi.org/10.1177/2050640617695067
Ianiro G, Simren M. How to get your work published: Tricks and pearls. United European Gastroenterol J. 2017 Mar;5(2):300-301. doi: 10.1177/2050640617695067. Epub 2017 Mar 01. PMID: 28344800; PMCID: PMC5349371.
Copy Download .nbib Format: NLM
Differential diagnosis of solid pancreatic masses: contrast-enhanced harmonic (CEH-EUS), quantitative-elastography (QE-EUS), or both?.

United European gastroenterology journal

Iglesias-Garcia J, Lindkvist B, Lariño-Noia J, Abdulkader-Nallib I, Dominguez-Muñoz JE.
PMID: 28344791
United European Gastroenterol J. 2017 Mar;5(2):236-246. doi: 10.1177/2050640616640635. Epub 2016 Jun 23.

BACKGROUND: Contrast-enhanced harmonic endoscopic ultrasound (CEH-EUS) and quantitative-elastography endoscopic ultrasound (QE-EUS) are considered useful tools for the evaluation of solid pancreatic tumors (SPT). The aim of our study was to evaluate the diagnostic accuracy of CEH-EUS, QE-EUS, and the...

Cite
Iglesias-Garcia J, Lindkvist B, Lariño-Noia J, et al. Differential diagnosis of solid pancreatic masses: contrast-enhanced harmonic (CEH-EUS), quantitative-elastography (QE-EUS), or both?. United European Gastroenterol J. 2016;5(2):236-246doi: 10.1177/2050640616640635.
Iglesias-Garcia, J., Lindkvist, B., Lariño-Noia, J., Abdulkader-Nallib, I., & Dominguez-Muñoz, J. E. (2017). Differential diagnosis of solid pancreatic masses: contrast-enhanced harmonic (CEH-EUS), quantitative-elastography (QE-EUS), or both?. United European gastroenterology journal, 5(2), 236-246. https://doi.org/10.1177/2050640616640635
Iglesias-Garcia, Julio, et al. "Differential diagnosis of solid pancreatic masses: contrast-enhanced harmonic (CEH-EUS), quantitative-elastography (QE-EUS), or both?." United European gastroenterology journal vol. 5,2 (2017): 236-246. doi: https://doi.org/10.1177/2050640616640635
Iglesias-Garcia J, Lindkvist B, Lariño-Noia J, Abdulkader-Nallib I, Dominguez-Muñoz JE. Differential diagnosis of solid pancreatic masses: contrast-enhanced harmonic (CEH-EUS), quantitative-elastography (QE-EUS), or both?. United European Gastroenterol J. 2017 Mar;5(2):236-246. doi: 10.1177/2050640616640635. Epub 2016 Jun 23. PMID: 28344791; PMCID: PMC5349356.
Copy Download .nbib Format: NLM
Rifabutin-based 10-day and 14-day triple therapy as a third-line and fourth-line regimen for Helicobacter pylori eradication: A pilot study.

United European gastroenterology journal

Mori H, Suzuki H, Matsuzaki J, Tsugawa H, Fukuhara S, Miyoshi S, Hirata K, Seino T, Matsushita M, Nishizawa T, Masaoka T, Kanai T.
PMID: 27403304
United European Gastroenterol J. 2016 Jun;4(3):380-7. doi: 10.1177/2050640615618043. Epub 2015 Nov 13.

BACKGROUND AND AIM: This prospective randomized study was designed to assess the efficacy of 10-day and 14-day rifabutin-based triple therapy as a third- or fourth-line rescue therapy.METHODS: Patients who failed first- and second-line eradication therapy were enrolled. H. pylori...

Cite
Mori H, Suzuki H, Matsuzaki J, et al. Rifabutin-based 10-day and 14-day triple therapy as a third-line and fourth-line regimen for Helicobacter pylori eradication: A pilot study. United European Gastroenterol J. 2015;4(3):380-7doi: 10.1177/2050640615618043.
Mori, H., Suzuki, H., Matsuzaki, J., Tsugawa, H., Fukuhara, S., Miyoshi, S., Hirata, K., Seino, T., Matsushita, M., Nishizawa, T., Masaoka, T., & Kanai, T. (2016). Rifabutin-based 10-day and 14-day triple therapy as a third-line and fourth-line regimen for Helicobacter pylori eradication: A pilot study. United European gastroenterology journal, 4(3), 380-7. https://doi.org/10.1177/2050640615618043
Mori, Hideki, et al. "Rifabutin-based 10-day and 14-day triple therapy as a third-line and fourth-line regimen for Helicobacter pylori eradication: A pilot study." United European gastroenterology journal vol. 4,3 (2016): 380-7. doi: https://doi.org/10.1177/2050640615618043
Mori H, Suzuki H, Matsuzaki J, Tsugawa H, Fukuhara S, Miyoshi S, Hirata K, Seino T, Matsushita M, Nishizawa T, Masaoka T, Kanai T. Rifabutin-based 10-day and 14-day triple therapy as a third-line and fourth-line regimen for Helicobacter pylori eradication: A pilot study. United European Gastroenterol J. 2016 Jun;4(3):380-7. doi: 10.1177/2050640615618043. Epub 2015 Nov 13. PMID: 27403304; PMCID: PMC4924440.
Copy Download .nbib Format: NLM
Temporary placement of fully covered self-expandable metal stents for the treatment of benign biliary strictures.

United European gastroenterology journal

Chaput U, Vienne A, Audureau E, Bauret P, Bichard P, Coumaros D, Napoléon B, Ponchon T, Duchmann JC, Laugier R, Lamouliatte H, Védrenne B, Gaudric M, Chaussade S, Robin F, Leblanc S, Prat F.
PMID: 27403307
United European Gastroenterol J. 2016 Jun;4(3):403-12. doi: 10.1177/2050640615606550. Epub 2015 Sep 24.

BACKGROUND: Endoscopic treatment of benign biliary strictures (BBS) can be challenging.OBJECTIVE: To evaluate the efficacy of fully covered self-expandable metal stents (FCSEMS) in BBS.METHODS: Ninety-two consecutive patients with BBS (chronic pancreatitis (n = 42), anastomotic after liver transplantation (n...

Cite
Chaput U, Vienne A, Audureau E, et al. Temporary placement of fully covered self-expandable metal stents for the treatment of benign biliary strictures. United European Gastroenterol J. 2015;4(3):403-12doi: 10.1177/2050640615606550.
Chaput, U., Vienne, A., Audureau, E., Bauret, P., Bichard, P., Coumaros, D., Napoléon, B., Ponchon, T., Duchmann, J. C., Laugier, R., Lamouliatte, H., Védrenne, B., Gaudric, M., Chaussade, S., Robin, F., Leblanc, S., & Prat, F. (2016). Temporary placement of fully covered self-expandable metal stents for the treatment of benign biliary strictures. United European gastroenterology journal, 4(3), 403-12. https://doi.org/10.1177/2050640615606550
Chaput, Ulriikka, et al. "Temporary placement of fully covered self-expandable metal stents for the treatment of benign biliary strictures." United European gastroenterology journal vol. 4,3 (2016): 403-12. doi: https://doi.org/10.1177/2050640615606550
Chaput U, Vienne A, Audureau E, Bauret P, Bichard P, Coumaros D, Napoléon B, Ponchon T, Duchmann JC, Laugier R, Lamouliatte H, Védrenne B, Gaudric M, Chaussade S, Robin F, Leblanc S, Prat F. Temporary placement of fully covered self-expandable metal stents for the treatment of benign biliary strictures. United European Gastroenterol J. 2016 Jun;4(3):403-12. doi: 10.1177/2050640615606550. Epub 2015 Sep 24. PMID: 27403307; PMCID: PMC4924429.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 893 entries